SELLAS Life Sciences (SLS) Net Margin (2013 - 2022)

SELLAS Life Sciences (SLS) reported Net Margin of 1673.5% for Q1 2022, down 163134.0% year-over-year from N/an in Q1 2021, and down 589.28% quarter-over-quarter from 242.79% in Q2 2021.

SELLAS Life Sciences (SLS) Net Margin (2013 - 2022) Analysis & Trends

SELLAS Life Sciences (SLS) has 6 years of Net Margin data on file, last reported at 1673.5% in Q1 2022.

  • Net Margin for Q1 2022 came in at 1673.5%, down 163134.0% year-over-year; the trailing twelve-month figure through Dec 2022 was 4195.0% (down 392264.0% YoY), and the FY2022 annual result was 4130.1%, down 385774.0% from the prior year.
  • Net Margin slipped to 1673.5% in Q1 2022 per SLS's latest filing, from 242.79% in the prior quarter.
  • Over five years, Net Margin peaked at 42.16% in Q1 2021 and troughed at 1673.5% in Q1 2022.
  • A 3-year average of 538.51% and a median of 219.18% in 2020 frame the typical range for Net Margin.
  • On a YoY basis, Net Margin climbed as much as 163134 bps in 2022 and fell as far as 163134 bps in 2022.
  • A 3-year view of Net Margin shows it stood at 195.58% in 2020, then fell by 24 bps to 242.79% in 2021, then tumbled by 589 bps to 1673.5% in 2022.
  • Business Quant data shows SLS's Net Margin at 1673.5% in Q1 2022, 242.79% in Q2 2021, and 42.16% in Q1 2021.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Margin (Qtr)
1 Alterity Therapeutics 925,601.88 Bn 925,601.85 Bn - -
2 Belite Bio 58,560.00 Bn 58,560.00 Bn - -
3 Quantum Biopharma 17,284.41 Bn 17,284.40 Bn - -
4 Legend Biotech 2,809.00 Bn 2,808.71 Bn 242.10 Mn 0.82%
5 Evaxion A 1,334.43 Bn 1,334.42 Bn - -
6 Akari Therapeutics 1,312.27 Bn 1,312.26 Bn - -
7 Psyence Biomedical 212.16 Bn 212.16 Bn - -
8 Vertex Pharmaceuticals 114.83 Bn 107.58 Bn 2.59 Bn 34.53%
9 Abivax 91.96 Bn 91.96 Bn - -
10 SELLAS Life Sciences 1.39 Bn 1.39 Bn - -

Historic Data

Download Data
DateValue
Mar 31, 2022 -1,673.50%
Jun 30, 2021 -242.79%
Mar 31, 2021 -42.16%
Dec 31, 2020 -195.58%
Jun 30, 2015 -64.64%
Mar 31, 2015 -81.13%
Dec 31, 2014 468.08%
Sep 30, 2014 -163.02%
Jun 30, 2014 -698.16%
Mar 31, 2014 -545.28%
Dec 31, 2013 167.48%
Jun 30, 2013 -411.71%
Mar 31, 2013 -427.66%